loginx

NEW CUSTOMER Create your account to get started today

Registerx

Name

E-mail

Password

Confirm password

Optional: How did you hear about us? (anonymous survey)

Please specify your answer:

RECOVER PASSWORD x

$0.00

home Driada Medical Weight Management Tirzepatide

COLLECTIONS

🎁 BUY 3 +1 FREE: PHARMACOM LABS INTERNATIONAL HGH - TEAM CHOICE SEMAGLUTIDE - TEAM CHOICE STEALTH KITS🔥 HOT DEALS: BUNDLES

MANUFACTURERS

Pharmacom Labs Pharmaqo Stealth Labs Ultima Pharma Dragon Pharma Nakon Medical Para Pharma Driada Medical Deus Medical Xeno Labs Sixpex Beligas Hilma Biocare Euro-Pharmacies Somatrop-Lab Abbott Abdi Ibrahim Aburaihan Aksufarma Ilac San Allergan Ali Raif Alium Anke Bio Amgen Apex Pharma Aptissen Astellas AstraZeneca Ajanta Pharma Alkem Laboratories Alto Aurochem Laboratories Argis Aspen Assos Atabay A-Tech Labs Ayset Balkan Pharmaceuticals Banford Bayer Bayer Zydus Pharma Becton Dickinson Belmed Berko Berlin-Chemie Besins Bilim Bioamino Labs BioTeq Labs Bharat Serums And Vaccines Boehringer Cadila Pharma Canada Peptides Centurion Laboratories Cipla Concern Pharma Conventional Syringes Daewoong Daiichi Sankyo Darnitsa Deva Dharam Distributors Dong-A Dosfarm Drogsan Drooc Pharma Eczacıbaşı Embil Europe GT Evalar Farmak Ferring Fidia Fortune Health Care Galenika German Remedies Genetic Pharma Genopharm GenSci Generics Grindex GSK HAB Pharma Hansel Healing Pharma Hemat Himalaya Hubio Pharm Hygene Pharma IBSA Ice Pharma Innventa Pharm Ipsen Intas Biopharmaceuticals Iran Hormone Jelfa Johnlee Pharmaceuticals Kanonpharma Kocak Farma Knoll Healthcare KRKA Liba Lilly Livzon Lizhu Bio Macleods Marten Meda Pharma Menarini Merck MSD Mustafa Nevzat Natco Pharma Neutec Nobel Novartis Novo Nordisk Odin Anabolics Omstal Pharma Organon Orion Corp Orva Ozon Parex Pharmacia & Upjohn Pharmacy Turkish Pfizer Pliva Ranbaxy RJ Bio Roche RSM Pharma Satan Pharma Sandoz Sanovel Schonen Servier SFM Signature Spectrum Pharma Sopharma Sun Pharma Sunrise Remedies Singani Pharma Takeda Teva Pharmaceutical UCB Vipro Lifescience Xantis Pharma Zerox Pharma Zdorovje Zee Laboratories Zhengzhou Pharma Zydus Cadila Healthcare

WAREHOUSES

Shipping from US Shipping from EU Shipping from Asia Shipping from Australia Shipping from Canada

Wholesale

DEUS MEDICAL

Tirzepatide

Customer Reviews

BOUGHT TOGETHER

Shipping options

$54.00

Customer Reviews

BOUGHT TOGETHER

Shipping options

Characteristics

                        
                        Active Substance
                    
                                    Tirzepatide
                                
                            FORM
                        
                            1 vial x 5 mg + water for injection
                        
                        Manufacturer
                    
                                Driada Medical

Description

TIRZEPATIDE - DRIADA MEDICAL

1 vial x 5 mg + water for injection

Tirzepatide is an innovative pharmacological agent that represents a significant advancement in the treatment of type 2 diabetes mellitus (T2DM) and obesity. Developed by Eli Lilly, this drug is a dual agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. These incretin hormones are naturally occurring peptides involved in the regulation of glucose homeostasis and energy balance. By simultaneously targeting these pathways, tirzepatide exerts a synergistic effect that enhances its efficacy in managing hyperglycemia and promoting weight loss, distinguishing it from existing therapies that typically target only the GLP-1 receptor.

The development of tirzepatide is rooted in the growing recognition of the need for more effective therapeutic options for patients with T2DM, particularly those who are also struggling with obesity. Traditional antidiabetic medications often fall short in addressing the multifaceted needs of these patients, especially in terms of weight management, which is a critical component of comprehensive diabetes care. Tirzepatide’s dual mechanism not only addresses the glucose control but also significantly impacts body weight, an area where many other therapies have limited success. The drug’s ability to achieve such significant outcomes has led to its consideration as a potential game-changer in both endocrinology and metabolic disease management.

Recent clinical trials have highlighted tirzepatide's remarkable efficacy. For instance, the SURPASS program, a series of Phase III clinical trials, demonstrated that tirzepatide could achieve superior reductions in HbA1c levels and body weight compared to other established therapies, including insulin and GLP-1 receptor agonists like semaglutide. The dual incretin agonism of tirzepatide offers a more comprehensive approach to T2DM and obesity, making it particularly appealing for patients who require both glycemic control and substantial weight loss. Furthermore, the drug's effects extend beyond these primary outcomes, potentially offering benefits in cardiovascular health and overall metabolic profile, making it an attractive option not just for diabetologists, but also for specialists in cardiology and endocrinology.

Given the growing epidemic of obesity and diabetes worldwide, the introduction of tirzepatide is timely. Its potential to address the dual challenges of hyperglycemia and obesity could redefine the standard of care for millions of patients globally. Moreover, its off-label use is already being explored in the bodybuilding and fitness communities, where its potent weight loss effects could provide an edge in fat reduction and metabolic optimization. However, the full spectrum of tirzepatide’s potential is still being studied, and ongoing research will likely continue to expand our understanding of its benefits and applications.